Our research projects are undertaken globally with research teams drawing together employees from different countries depending on their expertise. We have developed a global project management framework to facilitate collaboration across national and cultural boundaries and to harness the strength of our diversity.
We establish strategic partnerships with academic and other organisations globally to complement our in - house expertise. These collaborative partnerships support a range of programs including early - stage research and later stage development in plasma therapies, vaccines, and recombinant products. A range of advisers provide additional strategic insights into our product development initiatives.
We enter into collaborative agreements with third parties to further the science and prospects for successful product development. These partnerships often result in shared knowledge, intellectual property or products. The collaboration agreements address issues such as research funding, payment of milestones achieved and royalties. Where possible, we undertake activities at our laboratories and those of our collaborators, to facilitate growth of expertise and cross - fertilisation of ideas.